Mirae Asset Global Etfs Holdings Ltd. Hille Vax, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Hille Vax, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 13,016 shares of HLVX stock, worth $23,819. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,016Holding current value
$23,819% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HLVX
# of Institutions
93Shares Held
40.5MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$19.4 Million9.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4MShares$7.33 Million1.22% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.48MShares$6.37 Million0.03% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$3.83 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$3.64 Million0.01% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $61.2M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.